Know Cancer

or
forgot password

FOCUS GROUP EVALUATION OF PROSTATE CANCER SYMPTOM MANAGEMENT EDUCATION MATERIALS


N/A
18 Years
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

FOCUS GROUP EVALUATION OF PROSTATE CANCER SYMPTOM MANAGEMENT EDUCATION MATERIALS


OBJECTIVES:

- To collect formative evaluation data about a new educational intervention using focus
groups of patients with prostate cancer.

- To use the focus group data in the master's research paper of a Baylor College of
Medicine physician-assistant student who is documenting the process of organizing and
conducting the focus groups, enumerating areas where the new materials are deemed
problematic, and identifying themes in the comments made by the focus group
participants.

OUTLINE: Study participants are assigned to 1 of 3 focus groups according to educational
level and ethnicity (i.e., lower educational-level African-American men primarily from the
Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC); lower educational-level
Caucasian men from MEDVAMC, Baylor College of Medicine (BCM), or the community; or higher
educational-level Caucasian men primarily from BCM or the community).

Participants review written patient educational-intervention materials on prostate cancer
and provide feedback to the investigator on the content and acceptability of these materials
during a 1½-2-hour focus group discussion. Feedback data are used to revise the intervention
materials so that they are appropriate to the target population.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Biopsy-proven prostate cancer

- Localized disease that has been previously treated

- Selected for participation from 1 of the following:

- Convenience sample of men from the Baylor College of Medicine (BCM) Urology
clinics at Scurlock Tower (including the Urology clinic at MEDVAMC) and local
prostate cancer-support groups

- Prostate cancer survivors who participated in the US TOO Father's Day Walk/Run
or the Gay Pride Celebration

PATIENT CHARACTERISTICS:

- Able to speak and read in English

- Willing to review the written patient educational materials and discuss them in a
group setting

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

Type of Study:

Interventional

Study Design:

N/A

Outcome Measure:

Acceptability of the written patient educational materials, in terms of text size, white space, font, and graphics

Safety Issue:

No

Principal Investigator

David M. Latini, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Baylor College of Medicine

Authority:

United States: Federal Government

Study ID:

CDR0000600594

NCT ID:

NCT00769431

Start Date:

May 2008

Completion Date:

Related Keywords:

  • Prostate Cancer
  • stage I prostate cancer
  • stage IIB prostate cancer
  • stage IIA prostate cancer
  • Prostatic Neoplasms

Name

Location

Veterans Affairs Medical Center - Houston Houston, Texas  77030
Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, Texas  77030